Global Equine Pharmaceuticals and Supplements Competitive Landscape Professional Research Report 2025

Research Summary

Equine pharmaceuticals and supplements refer to a category of products specifically developed for the health and well-being of horses. These include a wide range of medications, treatments, and dietary supplements designed to address various equine health concerns and nutritional needs. Equine pharmaceuticals can encompass prescription drugs used to treat illnesses, infections, or injuries in horses, while supplements are typically non-prescription products used to support overall health, performance, and specific nutritional requirements. Common equine supplements include vitamins, minerals, joint supplements, digestive aids, and herbal remedies. The use of equine pharmaceuticals and supplements is essential in maintaining the health, performance, and longevity of horses, and their application can vary widely based on the individual horse＇s needs, activity level, and health conditions. These products are an integral part of modern equine healthcare and management.

According to DIResearch's in-depth investigation and research, the global Equine Pharmaceuticals and Supplements market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Equine Pharmaceuticals and Supplements include Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Equine Pharmaceuticals and Supplements. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Equine Pharmaceuticals and Supplements market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Equine Pharmaceuticals and Supplements market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Equine Pharmaceuticals and Supplements industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Equine Pharmaceuticals and Supplements Include:

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Equine Pharmaceuticals and Supplements Product Segment Include:

Saddles and accessories

Bridles & Attachments

Halters

Bits

Blankets

Protection Boots & Wraps

Hoods

Stirrups

Equine Pharmaceuticals and Supplements Product Application Include:

Children

Adults

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Equine Pharmaceuticals and Supplements Industry PESTEL Analysis

Chapter 3: Global Equine Pharmaceuticals and Supplements Industry Porter’s Five Forces Analysis

Chapter 4: Global Equine Pharmaceuticals and Supplements Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Equine Pharmaceuticals and Supplements Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Equine Pharmaceuticals and Supplements Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Equine Pharmaceuticals and Supplements Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources